Table 6. Overall survival since diagnosis (upper panel), progression free survival since nab-paclitaxel treatment (middle), overall survival since nab-paclitaxel therapy (lower panel).
Survival rate | Days | Month |
---|---|---|
OS (all) | ||
Mean | 659 | 22 |
Median | 644.5 | 21.5 |
PFS (since nab-paclitaxel) | ||
Mean | 221 | 7.4 |
Median | 181 | 6 |
OS (since nab-paclitaxel) | ||
Mean | 284 | 9.5 |
Median | 270 | 9 |
OS, overall survival; PFS, progression free survival.